Comparability of the age and sex distribution of the UK Clinical Practice Research Datalink and the total Dutch population

Publication date

2016-12

Authors

de Jong, Roy G P J
Gallagher, Arlene Marie
Herrett, Emily
Masclee, Ad A M
Janssen-Heijnen, Maryska L G
De Vries, F.ORCID 0000-0003-3837-8319ISNI 0000000393640594

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

taverne

Abstract

PURPOSE: The UK Clinical Practice Research Datalink (CPRD) is increasingly being used by Dutch researchers in epidemiology and pharmacoepidemiology. It is however unclear if the UK CPRD is representative of the Dutch population and whether study results would apply to the Dutch population. Therefore, as first step, our objective was to compare the age and sex distribution of the CPRD with the total Dutch population. METHODS: As a measure of representativeness, the age and sex distribution of the UK CPRD were visually and numerically compared with Dutch census data from the StatLine database of the Dutch National Bureau of Statistics in 2011. RESULTS: The age distribution of men and women in the CPRD population was comparable to the Dutch male and female population. Differences of more than 10% only occurred in older age categories (75+ in men and 80+ in women). CONCLUSIONS: Results from observational studies that have used CPRD data are applicable to the Dutch population, and a useful resource for decision making in the Netherlands. Nevertheless, differences in drug exposure likelihood between countries should be kept in mind, as these could still cause variations in the actual population studied, thereby decreasing its generalizability. Copyright © 2016 John Wiley & Sons, Ltd.

Keywords

representativeness, database, population-based, epidemiology, pharmacoepidemiology, Taverne

Citation

de Jong, R G P J, Gallagher, A M, Herrett, E, Masclee, A A M, Janssen-Heijnen, M L G & de Vries, F 2016, 'Comparability of the age and sex distribution of the UK Clinical Practice Research Datalink and the total Dutch population', Pharmacoepidemiology and Drug Safety, vol. 25, no. 12, pp. 1460-1464. https://doi.org/10.1002/pds.4074